| | Start date | Site | Title | Topic |
|---|
| ML25155A315 | 4 June 2025 | 11006621 | Export License Issued to Shine Technologies LLC for XB1370 | |
| ML25104A265 | 14 April 2025 | | M250408B: Transcript - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Brachytherapy
Overdose |
| ML25162A113 | 7 April 2025 | | Medical Events FY24 ACMUI Presentation | Brachytherapy
TheraSphere
Overexposure
Overdose
Underdose
Reactive Inspection |
| ML25127A173 | 7 April 2025 | | Transcript of Meeting of the Advisory Committee on the Medical Uses of Isotopes, April 7, 2025, Pages 1-162 | Cyber Security
Brachytherapy
TheraSphere
Overexposure
Overdose
Underdose
Reactive Inspection |
| ML25092A155 | 2 April 2025 | | Spring 2025 ACMUI Handout | Brachytherapy
TheraSphere
Overexposure
Overdose
Underdose
Reactive Inspection |
| ML25134A194 | 1 April 2025 | 03011072 | Union Hospital, Inc., NRC Form 592M, Inspection Report 03011072/2025001 | Brachytherapy |
| ML25070A205 | 11 March 2025 | 11006621 | Letter to U.S. Dept of State Requesting Eb Views for XB1370 | |
| ML25050A035 | 19 February 2025 | | Program Elements: Regulation and Non-Regulation | Decommissioning Funding Plan
Brachytherapy
TheraSphere |
| ML24317A125 | 4 November 2024 | | Transcript of Meeting on the Medical Uses of Isotopes Meeting November 4, 2024, Pages 1 - 142 | Enforcement Discretion
License Renewal
Subsequent License Renewal
Pandemic
COVID-19
Power Uprate
TheraSphere
Overexposure
Overdose |
| ML24319A037 | 4 November 2024 | | Transcript of Meeting of Advisory Committee on the Medical Uses of Isotopes November 4, 2024 Meeting Pages 1 - 142 Update | Enforcement Discretion
License Renewal
Subsequent License Renewal
Pandemic
COVID-19
Power Uprate
TheraSphere
Overexposure
Overdose |
| ML24276A096 | 7 October 2024 | Westinghouse | Meeting Summary for Westinghouse Electric Company 2024 Fuel Performance Update Closed Hybrid Meeting | Machine learning
Accident Tolerant Fuel |
| ML24176A082 | 17 June 2024 | | Draft Transcript of Meeting of the Advisory Committee on the Uses of Isotopes June 17 2024, Pages 1 - 93 | Brachytherapy |
| ML24109A127 | 18 April 2024 | | M240409B: Transcript - Meeting with Advisory Committee on the Medical Uses of Isotopes | Brachytherapy
Eye plaque
TheraSphere |
| ML24274A035 | 8 April 2024 | | FY24 - NRC Staff Medical Event Slides | Brachytherapy
Eye plaque
TheraSphere
Overdose
Underdose
Reactive Inspection |
| ML24106A178 | 18 March 2024 | | NRC Medical Event Slides, April 8, 2024, FY23 Events | Brachytherapy
Eye plaque
TheraSphere
Overdose
Underdose
Reactive Inspection |
| ML24085A017 | 14 March 2024 | | Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on Medical Events, Draft Report, March 14, 2024 | Brachytherapy
TheraSphere |
| ML24025A055 | 25 January 2024 | | M240118: Transcript - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines | Exemption Request
Brachytherapy
Backfit
Machine learning
Pre-submittal |
| ML23318A248 | 23 October 2023 | | ACMUI Fall Transcript | Decommissioning Funding Plan
Brachytherapy
TheraSphere
Overexposure
Underdose |
| ML23241A933 | 23 August 2023 | | T180-3 Effective 2021-06-15 Highlighted | Safe Shutdown
Incorporated by reference
Decommissioning Funding Plan
Authorized possession limits
License Renewal
Static Eliminator
Depleted uranium |
| SECY-23-0062, Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials | 24 July 2023 | | SECY-23-0062: Enclosure 2 - Proposed Rule Regulatory Analysis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials | Decommissioning Funding Plan
Authorized possession limits
License Renewal
Exemption Request
Backfit |
| ML23226A087 | 20 July 2023 | | Transcript of Information Meeting with Q&A Sessions on the Proposed Revision to Regulatory Guide 8.39 Release of Patients Administered Radioactive Material, Pages 1-118 | |
| ML23122A356 | 30 June 2023 | | Regulatory Basis: Rulemaking on Rubidium-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | Enforcement Discretion
Decommissioning Funding Plan
Exemption Request
Brachytherapy
TheraSphere |
| ML23186A027 | 8 June 2023 | | Emerging Medical Technologies | Brachytherapy |
| ML23156A532 | 31 May 2023 | | Alabama Radiation Control Rule, Licensing Rules, Chapter 420-3-2-.02 | Incorporated by reference
Decommissioning Funding Plan
Authorized possession limits
License Renewal
Static Eliminator
Stolen
Depleted uranium |
| ML23125A316 | 15 May 2023 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring 2023 Meeting Handout, May 15, 2023 | Decommissioning Funding Plan
Accidental discharge
Brachytherapy
Stolen
Eye plaque
TheraSphere
Overdose
Underdose |
| ML23125A317 | 5 May 2023 | | NRC Staff Medical Event Slides, May 15, 2023, FY22 Events | Accidental discharge
Brachytherapy
Eye plaque
TheraSphere
Overdose
Underdose |
| NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report | 31 January 2023 | | NUREG-2183, Supplement 1, Environmental Impact Statement Related to the Operating License for the Shine Medical Isotope Production Facility Final Report | Offsite Dose Calculation Manual
License Renewal
Environmental Justice
Depleted uranium |
| ML23034A206 | 26 January 2023 | | M230126: Transcript - Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines | License Renewal
Pandemic
COVID-19
Reactive Inspection
Pre-application |
| ENS 56310 | 14 December 2022 08:00:00 | Fred Hutchinson Cancer Center | Two Under Doses and Contaminated Individual | Spill |
| STC-22-074, Notification of Issuance of Revision of Licensing of LUTETIUM-177 | 9 December 2022 | | STC-22-074 - Notification of Issuance of Revision of Licensing of LUTETIUM-177 | |
| ML22318A150 | 8 December 2022 | | Memo to Regions - Revision of 2018 Memorandum to the Regions, Licensing of LUTETIUM-17 | |
| ML22348A040 | 6 December 2022 | | M221206: Transcript - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Enforcement Discretion
Brachytherapy
TheraSphere
Affidavit |
| ML22333B030 | 6 December 2022 | | M221206: Slides - Meeting with the Advisory Committee on the Medical Uses of Isotopes | Brachytherapy
TheraSphere |
| ML23012A007 | 5 December 2022 | | Transcript of Meeting of the Advisory Committee on Medical Uses of Isotopes (Acmui), December 5, 2022 | Enforcement Discretion
Decommissioning Funding Plan
Exemption Request
Pandemic
Brachytherapy
TheraSphere |
| ML22326A362 | 22 November 2022 | | Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review | Enforcement Discretion
Decommissioning Funding Plan
Exemption Request
Brachytherapy
TheraSphere |
| ML22243A213 | 30 August 2022 | | New Mexico Regulations Title 20 Chapter 3 Part 3 (Amended) | Incorporated by reference
Decommissioning Funding Plan
Authorized possession limits
License Renewal
Static Eliminator
Depleted uranium |
| ML22136A108 | 31 May 2022 | | Enforcement Program Annual Report, Calendar Year 2021 (Public) | Enforcement Discretion
Nondestructive Examination
Significance Determination Process
Notice of Violation
Pandemic
Coronavirus
COVID-19
Moisture Density Gauge |
| ML22145A584 | 27 April 2022 | 07007036 | Enclosure 2 - Summary Open Session | Pre-application |
| ML22063A454 | 26 April 2022 | | IP 87130 Nuclear Medicine Programs | Notice of Violation
Reactive Inspection |
| SECY-19-0125, Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125) | 22 April 2022 | | Regulatory Basis for Decommissioning Financial Assurance for Sealed and Unsealed Radioactive Materials (SRM-SECY-19-0125) | Decommissioning Funding Plan
Exemption Request
Backfit |
| ML22137A323 | 5 April 2022 | | NRC 2022 and ACMUI 2021 Medical Event Summary Presentations | Brachytherapy
Eye plaque
TheraSphere
Overdose
Underdose |
| ML22089A189 | 5 April 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Spring Meeting 2022 Handout | Brachytherapy
Stolen
TheraSphere
Overexposure
Overdose
Underdose |
| ML22112A104 | 5 April 2022 | | NRC Staff Medical Event Slide, April 5, 2022, FY21 | Brachytherapy
TheraSphere
Overdose
Underdose |
| ML22067A196 | 8 March 2022 | | Washington Regulations Ch 246-232 | License Renewal
Depleted uranium |
| ML22094A092 | 7 March 2022 | 03002271
03038167 | Washington University in St. Louis - NRC Form 591M Part 1, Inspection Report 03002271/2022001 and 03038167/2022001 | Notice of Violation
Brachytherapy
Eye plaque |
| IR 05000186/2021203 | 2 March 2022 | University of Missouri-Columbia | The Curators of the University of Missouri U.S. Nuclear Regulatory Commission Routine Inspection Report No. 05000186/2021203 | |
| ML22026A365 | 26 January 2022 | | CRCPD Part D Draft | High Radiation Area
Deep Dose Equivalent
Brachytherapy
Stolen |
| ML22021B299 | 21 January 2022 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39, Release of Patients Administered Radioactive Materials, Review and Comment on the Draft Civaderm Device Licensing Guidance, Final Report, January 21, 2022 | Brachytherapy
Eye plaque |
| ML22018A078 | 14 January 2022 | | Illinois Regulations Tracked Changes 32-IAC-330 | Static Eliminator
Depleted uranium |
| ML21341B436 | 15 December 2021 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) December 15, 2021 Teleconference Meeting Handout | Brachytherapy
Stolen
Eye plaque |